ARGENX SE | NL0010832176 | Euronext exchange Live quotes

Loading... Please wait.

Euronext Initiative dedicated to highlighting the visibility and attractiveness of high-growth and leading Tech companies towards international investors

Central order book

Loading... Please wait.

Historical Performance

Loading... Please wait.

Updated 11/04/2025 17:35 CEST

More Details
Download

Regulated news

Subscribe
See All

11/04/2025	argenx Announces Annual General Meeting of Shareholders on May 27, 2025
10/04/2025	argenx Announces FDA Approval of VYVGART Hytrulo Prefilled Syringe for Self-Injection in Generali...
08/04/2025	argenx Highlights VYVGART Data at AAN 2025 Setting New Standard in Sustained Efficacy and Improve...
07/03/2025	argenx Highlights FcRn Leadership with Long-term Data and Transformational Patient Outcomes at th...
27/02/2025	argenx Reports Full Year 2024 Financial Results and Provides Fourth Quarter Business Update

Central order book

Historical Performance

Regulated news

Related Instruments